EMEA-001693-PIP02-20
Key facts
| Active substance |
Reparixin
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0188/2021
|
| PIP number |
EMEA-001693-PIP02-20
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of coronavirus disease 2019 (COVID-2019)
|
| Route(s) of administration |
|
| Contact for public enquiries |
Dompé farmaceutici S.p.A.
E-mail: DAR@dompe.com |
| Decision type |
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)
|